RecensMedical Statistics

Total Valuation

RecensMedical has a market cap or net worth of KRW 321.71 billion. The enterprise value is 321.53 billion.

Market Cap	321.71B
Enterprise Value	321.53B

Important Dates

The next estimated earnings date is Monday, June 29, 2026.

Earnings Date	Jun 29, 2026
Ex-Dividend Date	n/a

Share Statistics

RecensMedical has 10.85 million shares outstanding. The number of shares has increased by 100.30% in one year.

Current Share Class	10.85M
Shares Outstanding	10.85M
Shares Change (YoY)	+100.30%
Shares Change (QoQ)	+174.07%
Owned by Insiders (%)	20.05%
Owned by Institutions (%)	9.05%
Float	6.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.44
PB Ratio	46.11
P/TBV Ratio	46.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.82
EV / Sales	36.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-34.37

Financial Position

The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.12.

Current Ratio	2.69
Quick Ratio	1.42
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	-4.42

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-41.43%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-119.70%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.55
Inventory Turnover	1.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	71.81
Average Volume (20 Days)	1,874,111

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RecensMedical had revenue of KRW 8.83 billion and -19.12 billion in losses. Loss per share was -2,890.00.

Revenue	8.83B
Gross Profit	4.31B
Operating Income	-10.64B
Pretax Income	-19.12B
Net Income	-19.12B
EBITDA	-10.13B
EBIT	-10.64B
Loss Per Share	-2,890.00

Full Income Statement

Balance Sheet

The company has 987.51 million in cash and 804.72 million in debt, giving a net cash position of 182.79 million or 16.85 per share.

Cash & Cash Equivalents	987.51M
Total Debt	804.72M
Net Cash	182.79M
Net Cash Per Share	16.85
Equity (Book Value)	6.98B
Book Value Per Share	740.33
Working Capital	5.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.59 billion and capital expenditures -760.59 million, giving a free cash flow of -9.35 billion.

Operating Cash Flow	-8.59B
Capital Expenditures	-760.59M
Depreciation & Amortization	509.91M
Net Borrowing	-330.23M
Free Cash Flow	-9.35B
FCF Per Share	-862.13

Full Cash Flow Statement

Margins

Gross margin is 48.81%, with operating and profit margins of -120.52% and -216.56%.

Gross Margin	48.81%
Operating Margin	-120.52%
Pretax Margin	-216.56%
Profit Margin	-216.56%
EBITDA Margin	-114.75%
EBIT Margin	-120.52%
FCF Margin	n/a

Dividends & Yields

RecensMedical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-100.30%
Shareholder Yield	-100.30%
Earnings Yield	-5.94%
FCF Yield	-2.91%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RecensMedical has an Altman Z-Score of -15.26 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.26
Piotroski F-Score	4